Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 7 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Q2 2023 vs. Q1 2023
How the institutions holding Roivant Sciences Ltd. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 147 | 1 | 182 | +36 |
| Shares | 459.4M | 27.0K | 499.1M | +39.8M (+8.7%) |
| Value | $3.39B | $199.3K | $5.03B | +$1.64B (+48.4%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (59)
Institutions that held Roivant Sciences Ltd. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (23)
Institutions that held Roivant Sciences Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 1,091,602 | $8.06M |
| Whitefort Capital Management, LP | 833,471 | $6.15M |
| Alyeska Investment Group, L.P. | 561,612 | $4.14M |
| Alps Advisors Inc | 499,683 | $3.69M |
| Rokos Capital Management LLP | 300,000 | $2.24M |
| Alpine Global Management, LLC | 300,000 | $2.21M |
| Magnetar Financial LLC | 150,000 | $1.11M |
| Segantii Capital Management Ltd | 102,170 | $754.0K |
| Affinity Asset Advisors, LLC | 100,000 | $738.0K |
| PDT Partners, LLC | 69,769 | $514.9K |
| PEAK6 Investments LLC | 66,934 | $494.0K |
| Squarepoint Ops LLC | 54,174 | $399.8K |
| Pathstone Family Office, LLC | 38,488 | $284.0K |
| Shay Capital LLC | 25,000 | $184.5K |
| Verition Fund Management LLC | 15,946 | $117.7K |
| Twinbeech Capital LP | 10,970 | $81.0K |
| Sandia Investment Management LP | 10,000 | $73.8K |
| Eisler Capital (UK) Ltd. | 45,221 | $66.0K |
| Values First Advisors, Inc. | 6,581 | $48.6K |
| Belvedere Trading LLC | 5,054 | $37.3K |
| Lindbrook Capital, LLC | 86 | $635 |
| US Bancorp | 79 | $583 |
| Elequin Capital LP | 1 | $7 |
Not filed for Q2 2023 yet (1)
Institutions that held Roivant Sciences Ltd. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| CTC Capital Management, LLC | 27,000 | $199.3K |